期刊文献+

脑钠肽在心血管中的应用 被引量:2

Application of brain natriuretic peptide in clinical diagnosis of cardiovascular diseases
下载PDF
导出
摘要 目的为了深入研究脑钠肽在临床诊断心血管疾病中的应用价值。方法选取2013年1月到2014年3月在我院心血管内科进行住院治疗的心衰病患136例,将这些病患作为治疗组,同时选取这一期间体检健康者60人,将其作为对照组,对比治疗组与对照组脑钠肽平与心功能状况等指标。结果治疗组中病患脑钠肽浓度明显高于对照组,P<0.01,具有显著的统计学意义;治疗组脑钠肽浓度随着心功能恶化逐渐升高,和心功能等级有着显著关联,P<0.01,具有显著的统计学意义。结论脑钠肽是慢性心力衰竭的重要预警指标,它和心功能等级有着显著的关联,因此快速测定脑钠肽的浓度有助于心血管疾病的及时诊断与治疗。 Objective To study the value of brain natriuretic peptide (BNP) in the clinical diagnosis of cardiovascular diseases. Methods A total of 136 patients with heart failure hospitalized in Department of Cardiology of our hospital from January 2013 to March 2014 were selected as treatment group, and another 60 healthy individuals were selected as control group. BNP level and cardiac function were compared between the treatment group and the control group. Results The concentration of BNP in the treatment group was significantly higher than that in the control group (P〈0.01). For the treatment group, the concentration of BNP was increased with the aggravation of cardiac function, with a significant correlation between them (P〈0.01). Conclusion BNP is an important predictive marker of chronic heart failure, and it is significantly correlated with cardiac function. Therefore, rapid determination of BNP levels contributes to timely diagnosis and treatment of cardiovascular diseases.
作者 宋丽娟
出处 《心血管病防治知识(学术版)》 2014年第7期4-5,共2页 Prevention and Treatment of Cardiovascular Disease
关键词 心血管病学 脑钠肽 心血管疾病 临床应用 诊断价值 Cardiovascular diseases Brain natriuretic peptide Clinical application Diagnostic value
  • 相关文献

参考文献4

二级参考文献39

  • 1张书富,华尔铨,何祚佑,郑鹏翔,陈德,徐虹,马瑾,周依蒙,张斌.快速测定脑利钠肽预测充血性心力衰竭患者预后的价值[J].临床内科杂志,2004,21(8):522-523. 被引量:8
  • 2邵春来,洪小苏,陈建昌,高岚,徐卫亭,江建良.原发性高血压患者血浆利钠肽水平的变化[J].苏州大学学报(医学版),2005,25(1):101-103. 被引量:4
  • 3胡咏梅,赵思勤,李秋,聂晓莉,吴涛,刘小蓉,王勉,张文勇.慢性心力衰竭患者血浆脑钠肽和内皮素-1水平与血流动力学的相关性[J].临床心血管病杂志,2006,22(11):672-674. 被引量:27
  • 4Almeida P, Azevedo A, Rodrigues R, et al. B-type natriuretie peptide and left ventricular hypertrophy in hypertensive patients. Rev-Port-Cardiol,2003 ,22 :327-336.
  • 5Vasan, R S, Benjamin E J, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA, 2002, 288: 1252- 1259.
  • 6Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. NEJM,2004,350:655- 663.
  • 7Tsutamoto T, Wado A, Maedo K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997,96 : 509 -516.
  • 8Berger R, Huelsmann M, Strecker K, et al. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. Eur J Clin Invest,2005,35:24-31.
  • 9de Bold AJ,Borenstein HB,Verss AT,et al.A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.Life Sci,1981,28:89-94.
  • 10Maisel AS,Mc Cord J,Nowak RM,et al.Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction.Results from the Breathing Not Properly Multinational Study.J Am Coll Cardiol,2003,41:2010-2017.

共引文献33

同被引文献3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部